Callodine Capital Management LP Buys 205,882 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Callodine Capital Management LP grew its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 25.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,030,882 shares of the pharmacy operator's stock after acquiring an additional 205,882 shares during the quarter. Walgreens Boots Alliance comprises about 2.0% of Callodine Capital Management LP's investment portfolio, making the stock its 18th biggest holding. Callodine Capital Management LP owned 0.12% of Walgreens Boots Alliance worth $9,618,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in WBA. Swedbank AB increased its position in shares of Walgreens Boots Alliance by 45.3% during the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after purchasing an additional 185,762 shares during the last quarter. Merit Financial Group LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $326,000. Assenagon Asset Management S.A. raised its position in Walgreens Boots Alliance by 2,599.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 622,703 shares of the pharmacy operator's stock worth $5,810,000 after acquiring an additional 599,637 shares during the period. Orca Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $322,000. Finally, Sound Income Strategies LLC grew its position in shares of Walgreens Boots Alliance by 4.8% during the 4th quarter. Sound Income Strategies LLC now owns 507,213 shares of the pharmacy operator's stock valued at $4,732,000 after acquiring an additional 23,373 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ WBA traded up $0.02 during trading on Wednesday, hitting $11.01. 5,168,654 shares of the stock traded hands, compared to its average volume of 20,974,584. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The firm has a 50-day simple moving average of $10.90 and a 200-day simple moving average of $10.17. The company has a market capitalization of $9.52 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. During the same period last year, the firm posted $1.20 earnings per share. Walgreens Boots Alliance's revenue for the quarter was up 4.1% compared to the same quarter last year. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

WBA has been the topic of several analyst reports. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research note on Monday, January 13th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.